Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients
Status:
Terminated
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The aim of this randomized study is to compare the effect of pioglitazone versus placebo on
change in limb fat in HIV 1-infected patients treated with antiretroviral therapy for at
least 6 months and with clinical lipoatrophy.
Phase:
Phase 3
Details
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis